Shanghai, China

Linlin Yang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Linlin Yang: Innovator in Antibody Development

Introduction

Linlin Yang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. Her innovative work focuses on targeting specific proteins involved in cancer progression.

Latest Patents

Linlin Yang holds a patent for an antibody targeting claudin 18A2, which is crucial in cancer treatment. The patent, titled "Antibody for anti-claudin 18A2 and use thereof," describes methods for inducing cell death and treating tumors. This invention represents a significant advancement in cancer therapy, offering new hope for patients.

Career Highlights

Throughout her career, Linlin has worked with notable companies in the biotechnology sector. She has been associated with Cafa Therapeutics Limited and Crage Medical Co., Limited, where she has contributed her expertise in antibody development and cancer research.

Collaborations

Linlin Yang has collaborated with esteemed colleagues, including Peng Wang and Hua Jiang. These partnerships have enhanced her research and development efforts, leading to innovative solutions in the field of cancer treatment.

Conclusion

Linlin Yang's work in antibody development showcases her dedication to advancing medical science. Her innovative patent and collaborations highlight her impact on cancer research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…